Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 1
2020 2
2021 6
2022 4
2023 8
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Multiparametric Magnetic Resonance Imaging in Prostate Cancer Screening at the Age of 45 Years: Results from the First Screening Round of the PROBASE Trial.
Boschheidgen M, Albers P, Schlemmer HP, Hellms S, Bonekamp D, Sauter A, Hadaschik B, Krilaviciute A, Radtke JP, Seibold P, Lakes J, Arsov C, Gschwend JE, Herkommer K, Makowski M, Kuczyk MA, Wacker F, Harke N, Debus J, Körber SA, Benner A, Kristiansen G, Giesel FL, Antoch G, Kaaks R, Becker N, Schimmöller L. Boschheidgen M, et al. Eur Urol. 2024 Feb;85(2):105-111. doi: 10.1016/j.eururo.2023.09.027. Epub 2023 Oct 18. Eur Urol. 2024. PMID: 37863727
[PIRADS-5 cases with negative targeted MRI/US fusion-guided biopsy].
Kasprowski L, Ullrich T, Boschheidgen M, Lopez-Cotarelo C, Kristiansen G, Albers P, Antoch G, Schimmöller L. Kasprowski L, et al. Among authors: boschheidgen m. Rofo. 2022 Mar;194(3):241-244. doi: 10.1055/a-1584-0221. Epub 2021 Dec 15. Rofo. 2022. PMID: 34911137 German. No abstract available.
Prediction of therapy response of breast cancer patients with machine learning based on clinical data and imaging data derived from breast [18F]FDG-PET/MRI.
Jannusch K, Dietzel F, Bruckmann NM, Morawitz J, Boschheidgen M, Minko P, Bittner AK, Mohrmann S, Quick HH, Herrmann K, Umutlu L, Antoch G, Rubbert C, Kirchner J, Caspers J. Jannusch K, et al. Among authors: boschheidgen m. Eur J Nucl Med Mol Imaging. 2024 Apr;51(5):1451-1461. doi: 10.1007/s00259-023-06513-9. Epub 2023 Dec 22. Eur J Nucl Med Mol Imaging. 2024. PMID: 38133687 Free PMC article.
Recurrent prostate cancer: combined role for MRI and PSMA-PET in 68Ga-PSMA-11 PET/MRI.
Jannusch K, Bruckmann NM, Morawitz J, Boschheidgen M, Quick HH, Herrmann K, Fendler WP, Umutlu L, Stuschke M, Hadaschik B, Antoch G, Schimmöller L, Kirchner J. Jannusch K, et al. Among authors: boschheidgen m. Eur Radiol. 2023 Dec 1. doi: 10.1007/s00330-023-10442-4. Online ahead of print. Eur Radiol. 2023. PMID: 38038758
Chemical Exchange Saturation Transfer for Lactate-Weighted Imaging at 3 T MRI: Comprehensive In Silico, In Vitro, In Situ, and In Vivo Evaluations.
Radke KL, Abrar DB, Frenken M, Wilms LM, Kamp B, Boschheidgen M, Liebig P, Ljimani A, Filler TJ, Antoch G, Nebelung S, Wittsack HJ, Müller-Lutz A. Radke KL, et al. Among authors: boschheidgen m. Tomography. 2022 May 7;8(3):1277-1292. doi: 10.3390/tomography8030106. Tomography. 2022. PMID: 35645392 Free PMC article.
21 results